THE EFFECT OF THE PLASMA-LEVELS OF PROTEIN-C AND PROTEIN-S ON THE PREDICTION OF WARFARIN MAINTENANCE DOSE REQUIREMENTS

被引:3
作者
LUBETSKY, A
SELIGSOHN, U
EZRA, D
HALKIN, H
机构
[1] CHAIM SHEBA MED CTR, DEPT MED A, IL-52621 TEL HASHOMER, ISRAEL
[2] TEL AVIV UNIV, ICHILOV HOSP, INST HEMATOL, IL-69978 TEL AVIV, ISRAEL
[3] TEL AVIV UNIV, SACKLER SCH MED, TEL AVIV, ISRAEL
关键词
D O I
10.1038/clpt.1992.101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Determination of the effects of the vitamin K-dependent anticoagulants, proteins C and S, on warfarin dose requirements and on the prediction error of a bayesian warfarin dose predicting program. Methods: Patients in the study were consecutive inpatients (n = 18) starting treatment with warfarin who were monitored as outpatients for 4 weeks. The following measurements were taken: repeated (n = 8) prothrombin times, expressed as the international normalized ratio (INR), plasma protein C and S antigen levels (percentage of pooled normal plasma), demographic, clinical and biochemical variables. Results: Maintenance doses (adjusted to INR 2.5) were 6.7 +/- 3.4 mg/day. Protein C decreased to 56.9% +/- 15.3%, protein S to 63.7% +/- 17.3%, INR increased to 2.46 +/- 0.14. Prediction error decreased from 2.84 +/- 2.0 mg/day to 0.95 +/- 0.78 mg/day. Protein C accounted for only 4.2% of the mean maintenance dose but protein C and S levels accounted for 31% of the mean dose prediction error. Conclusion: Protein C and S levels affect warfarin doses and predictions significantly but not to a clinically meaningful degree.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 37 条
  • [1] EVALUATION OF A COMPUTER-ASSISTED METHOD FOR INDIVIDUALIZED ANTICOAGULATION - RETROSPECTIVE AND PROSPECTIVE STUDIES WITH A PHARMACODYNAMIC MODEL
    ABBRECHT, PH
    OLEARY, TJ
    BEHRENDT, DM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) : 129 - 136
  • [2] HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON
    ALVING, BM
    STRICKLER, MP
    KNIGHT, RD
    BARR, CF
    BERENBERG, JL
    PECK, CC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) : 499 - 501
  • [3] Bovill E G, 1987, Adv Exp Med Biol, V214, P17
  • [4] EVALUATION OF A BAYESIAN REGRESSION PROGRAM FOR PREDICTING WARFARIN RESPONSE
    BOYLE, DA
    LUDDEN, TM
    CARTER, BL
    BECKER, AJ
    TAYLOR, JW
    [J]. THERAPEUTIC DRUG MONITORING, 1989, 11 (03) : 276 - 284
  • [5] BROEKMANS AW, 1983, THROMB HAEMOSTASIS, V49, P251
  • [6] CERMEER C, 1991, THROMB HAEMOSTASIS, V66, P153
  • [7] THE REGULATION OF HEMOSTASIS - THE PROTEIN-C SYSTEM
    CLOUSE, LH
    COMP, PC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20) : 1298 - 1304
  • [8] RELATIONSHIP BETWEEN PROTEIN-C ANTIGEN AND ANTICOAGULANT ACTIVITY DURING ORAL ANTICOAGULATION AND IN SELECTED DISEASE STATES
    DANGELO, SV
    COMP, PC
    ESMON, CT
    DANGELO, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) : 416 - 425
  • [9] DRAPER NR, 1981, APPLIED REGRESSION A, P207
  • [10] THERAPEUTIC CONTROL OF ANTICOAGULANT TREATMENT
    DUXBURY, BM
    [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6317) : 702 - 704